Pedro Lichtinger, Director at Gemphire Therapeutics Inc. (GEMP), bought 21,118 shares at $9.47 ($200K) on 2017-03-10, disclosed to the SEC on 2017-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.47 | 10,559 | $100K | 50.0% |
| 2 | $9.47 | 10,559 | $100K | 50.0% |
| Total | $9.47 avg | 21,118 | $200K | 100% |
| Filing → |
| OPTR | SELL | 2013-04-10 | $2.2M | — | Filing → |
| OPTR | BUY | 2012-11-19 | $100K | — | Filing → |
| BTX | BUY | 2012-04-12 | $25K | — | Filing → |